PAPSS1
Basic information
Region (hg38): 4:107590276-107720234
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAPSS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 37 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 0 | 0 |
Variants in PAPSS1
This is a list of pathogenic ClinVar variants found in the PAPSS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-107614260-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
4-107614269-T-G | not specified | Uncertain significance (Nov 17, 2022) | ||
4-107614301-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
4-107614323-G-T | not specified | Uncertain significance (Jun 21, 2022) | ||
4-107614337-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
4-107614377-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
4-107631640-T-C | not specified | Uncertain significance (May 21, 2024) | ||
4-107631655-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
4-107631695-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
4-107631737-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
4-107631740-C-A | not specified | Uncertain significance (Mar 18, 2024) | ||
4-107631779-G-T | not specified | Uncertain significance (Jul 26, 2022) | ||
4-107644804-C-T | not specified | Uncertain significance (May 17, 2023) | ||
4-107644863-T-G | not specified | Uncertain significance (Jul 14, 2022) | ||
4-107644893-T-C | not specified | Uncertain significance (May 05, 2023) | ||
4-107644895-C-G | not specified | Uncertain significance (May 18, 2022) | ||
4-107644906-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
4-107644918-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
4-107644926-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
4-107644932-T-G | not specified | Uncertain significance (Jun 04, 2024) | ||
4-107644939-A-G | not specified | Uncertain significance (Dec 21, 2022) | ||
4-107644974-C-T | not specified | Uncertain significance (Jan 11, 2023) | ||
4-107644975-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
4-107644981-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
4-107645044-T-G | not specified | Uncertain significance (Jun 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PAPSS1 | protein_coding | protein_coding | ENST00000265174 | 12 | 130176 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.33e-8 | 0.994 | 125527 | 0 | 221 | 125748 | 0.000879 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.74 | 263 | 355 | 0.740 | 0.0000192 | 4088 |
Missense in Polyphen | 108 | 156.71 | 0.68919 | 1697 | ||
Synonymous | -0.107 | 122 | 121 | 1.01 | 0.00000605 | 1192 |
Loss of Function | 2.48 | 17 | 32.2 | 0.528 | 0.00000183 | 365 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000445 | 0.000445 |
Ashkenazi Jewish | 0.0141 | 0.0142 |
East Asian | 0.000382 | 0.000381 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000375 | 0.000369 |
Middle Eastern | 0.000382 | 0.000381 |
South Asian | 0.000392 | 0.000392 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate- activation pathway (PubMed:9576487, PubMed:9668121, PubMed:9648242, PubMed:14747722). Required for normal biosynthesis of sulfated L-selectin ligands in endothelial cells (PubMed:9576487). {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121}.;
- Pathway
- Selenocompound metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Sulfur metabolism - Homo sapiens (human);Selenoamino Acid Metabolism;Sulfation Biotransformation Reaction;Disease;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se;Transport and synthesis of PAPS;Metabolism of carbohydrates;Phase II - Conjugation of compounds;Glycosaminoglycan metabolism;sulfate activation for sulfonation;Metabolism of amino acids and derivatives;Biological oxidations;Metabolism;Selenoamino acid metabolism;Cytosolic sulfonation of small molecules;Purine nucleotides nucleosides metabolism;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.168
Intolerance Scores
- loftool
- 0.755
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.46
Haploinsufficiency Scores
- pHI
- 0.369
- hipred
- N
- hipred_score
- 0.454
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Papss1
- Phenotype
Gene ontology
- Biological process
- sulfate assimilation;skeletal system development;phosphorylation;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process
- Cellular component
- cytosol
- Molecular function
- adenylylsulfate kinase activity;sulfate adenylyltransferase (ATP) activity;ATP binding;nucleotidyltransferase activity;protein homodimerization activity